Latest Breaking News On - Evan ballantyne - Page 3 : comparemela.com

Evan Ballantyne to join Hansa Biopharma as Chief Financial Officer

/PRNewswire/ Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), today announced the appointment of Evan Ballantyne as Chief Financial Officer (CFO),.

United statesUnited kingdomBritish columbiaPrnewswire hansa biopharmaStephanie kenneyDonato spotaEvan ballantyneKlaus sindahlHansa biopharmaHansa executive committeePreveceutical medical incHonors business administrationUniversity of windsorGain therapeutics incVp global corporate affairsUniversity of western ontario

Gain Therapeutics Reports First Quarter 2023 Financial Results and Business Update

Successfully completed GLP toxicology studies for lead program GT-02287 in GBA1 Parkinson’s diseaseCompany is on track to submit application for start of Phase 1 clinical trial of GT-02287 to. | May 12, 2023

Vastra gotalands lanEteläuomen läiMatthias alderC evan ballantyneEvan ballantyneGain therapeutics incCompany annual report on formExchange commission onSilverstein foundation for parkinsonHuman research ethics committeeUniversity of helsinkiInstitute for researchEuropean union horizonInternational conference on alzheimerExchange commissionMichaelj fox foundation for parkinson research

Citigroup CFO on how careers are defined in times of crisis

Mark Mason discusses the regional bank turmoil but also shares how an earlier crisis shaped his career.

Hudson riverNew yorkUnited statesGary crittendenThomas castellanoCiti morgan stanleySheryl estradaC evan ballantyneMike corbatSalvatore calabreseJane fraserMark masonChristopher blakeVernon jordanRicky hopsonCiti holdings

Gain Therapeutics Appoints C Evan Ballantyne as Chief Financial Officer

Gain Therapeutics Appoints C Evan Ballantyne as Chief Financial Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Salvatore calabreseMatthias alderEvan ballantyneC evan ballantyneCompany annual report on formExchange commission onOrchestra biomed incSynthetic biologics incExchange commissionEuropean union horizonMichaelj fox foundation for parkinson researchClinical data incGain therapeutics incAgenus incUniversity of windsorSilverstein foundation for parkinson

Gain Therapeutics Appoints C Evan Ballantyne as Chief Financial Officer

BETHESDA, Md., April 12, 2023 Gain Therapeutics, Inc. , a biotechnology company leading the discovery and development of allosteric small molecule therapies, today announced the appointment of. | June 19, 2023

Evan ballantyneMatthias alderC evan ballantyneSalvatore calabreseMichaelj fox foundation for parkinson researchHealth scienceGain therapeutics incOrchestra biomed incSilverstein foundation for parkinsonExchange commission onSynthetic biologics incCerecin incClinical data incExchange commissionCompany annual report on formUniversity of western ontario